Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Non-GAAP other income adjustments by Year
Non-GAAP other income (expense) adjustments (equity securities fair value, $M) ($M)
Gilead Sciences Non-GAAP other income adjustments: -$451M in FY2025, down 264.6% from a year earlier.
Where the FY2025 figure comes from
“|| Other (income) expense, net, adjustments | (252) | 126 | (451) | 274”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP other income (expense) adjustments (equity securities fair value, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -451 | -264.6% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 274 | +64.1% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 167 | -74.6% | Form 8-K (exhibit991earningspressrel.htm, filed 2025-02-11) ↗ |
| FY2022 | Dec 31, 2022 | 657 | +7.7% | Form 8-K (exhibit991earningspressrel.htm, filed 2024-02-06) ↗ |
| FY2021 | Dec 31, 2021 | 610 | -63.4% | Form 8-K (exhibit991earningspressrel.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 1,667 | -234.3% | Form 8-K (exhibit991earningspressrel.htm, filed 2022-02-01) ↗ |
| FY2019 | Dec 31, 2019 | -1,241 | +979.1% | Form 8-K (exhibit991earningspressrel.htm, filed 2021-02-04) ↗ |
| FY2018 | Dec 31, 2018 | -115 | – | Form 8-K (exhibit991earningspres.htm, filed 2020-02-04) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Non-GAAP other income adjustments ($M), annual FY2018–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-adj-other-inc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.